Tarsus Pharmaceuticals, Inc. TARS Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s common stock, par value (in dollars per share)?
- Tarsus Pharmaceuticals, Inc. (TARS) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s common stock, par value (in dollars per share) changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.